Lymphohistiocytosis, Hemophagocytic Recruiting Phase 2 Trials for Tocilizumab (DB06273)

Also known as: Hemophagocytic Lymphohistiocytosis / Erythrophagia / Histiocytosis hematophagic / Histiocytosis haematophagic / Haemophagocytosis / Hemophagocytosis / Haemophagocytic lymphohistiocytosis / Familial hemophagocytic reticulosis

IndicationStatusPhase
DBCOND0001493 (Lymphohistiocytosis, Hemophagocytic)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02007239Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)Treatment